Vor Biopharma Inc.
VOR- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001817229
In the last 90 days, Vor Biopharma Inc. insiders filed 0 open-market purchases and 1 sale; 102 institutions reported holding it in 13F filings for Q2 2026, worth $893.0M in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Vor Biopharma Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Of which not filed for Q3 2021 | Q3 2021 | Change |
|---|---|---|---|---|
| Holders | 51 | 1 | 55 | +5 |
| Shares | 30.8M | 1.07M | 30.7M | +991.3K (+3.3%) |
| Value | $571.2M | $20.0M | $481.2M | −$69.9M (−12.7%) |
1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (9)
Institutions that held Vor Biopharma Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Johnson & Johnson | 1,074,658 | $16.9M | 1.48% |
| Qube Research & Technologies Ltd | 14,005 | $220.0K | 0.00% |
| SG Americas Securities, LLC | 10,868 | $170.0K | 0.00% |
| MetLife Investment Management | 8,268 | $129.6K | 0.00% |
| Metropolitan Life Insurance Co | 6,255 | $98.1K | 0.00% |
| Northwestern Mutual Wealth Management Co | 250 | $4.00K | 0.00% |
| US Bancorp | 112 | $2.00K | 0.00% |
| Captrust Financial Advisors | 37 | $1.00K | 0.00% |
| Ellevest, Inc. | 10 | $0 | 0.00% |
Sold out (4)
Institutions that held Vor Biopharma Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Sectoral Asset Management Inc | 405,324 | $7.56M |
| Highland Capital Management Fund Advisors, L.P. | 50,000 | $933.0K |
| Millennium Management LLC | 18,339 | $342.0K |
| Eagle Bay Advisors LLC | 150 | $3.00K |
Not filed for Q3 2021 yet (1)
Institutions that held Vor Biopharma Inc. at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Johnson & Johnson Innovation - JJDC, Inc. | 1,074,658 | $20.0M |